Testing spinal cord stimulation for chronic pain relief

Effects of Spinal Cord Stimulation

NA · University of Aarhus · NCT05885061

This study tests whether turning spinal cord stimulation on or off can help people with chronic pain feel better.

Quick facts

PhaseNA
Study typeInterventional
Enrollment25 (estimated)
Ages18 Years to 99 Years
SexAll
SponsorUniversity of Aarhus (other)
Locations1 site (Aarhus)
Trial IDNCT05885061 on ClinicalTrials.gov

What this trial studies

This interventional study aims to evaluate the effects of spinal cord stimulation (SCS) on patients suffering from chronic pain. Participants will compare their pain levels while using SCS turned on versus turned off, allowing researchers to assess the effectiveness of the treatment. The study focuses on patients who have had SCS implanted for at least six months and are currently experiencing chronic pain. By measuring pain scores, the study seeks to determine the true impact of SCS on pain management.

Who should consider this trial

Good fit: Ideal candidates are adults over 18 years old who have had spinal cord stimulation implanted for chronic pain for at least six months.

Not a fit: Patients currently receiving other neuromodulation treatments or who have recently changed their pain medication may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide a more effective pain management option for patients with chronic pain.

How similar studies have performed: Previous studies on spinal cord stimulation have shown promising results, indicating that this approach is not entirely novel but continues to be explored for its efficacy.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients (\>18 years of age) with SCS implanted to treat chronic pain.
* Patients who consent to participation and can cooperate in the study.
* Use of continuous paresthesia-free SCS for minimum 6 months prior to participation in the study.
* Pain score of 7 or less on a 0-10 scale in the most painful area treated with SCS, rated upon inclusion.
* Patients not receiving other neuromodulation treatment.
* Patients who have not undergone changes in their (pain relevant) medication during the last 30 days (pro necessitate medication allowed).

Where this trial is running

Aarhus

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Chronic Pain

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.